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Abstract 
A retrospective, strict matched-pair analysis on 728 treatment cycles between January 
2011 and September 2014 was performed. 364 treatment cycles, where all embryos were 
cultured and examined in EmbryoScope®, were matched to treatment cycles where all 
embryos were cultured in a standard incubator with conventional morphological 
examination. Matching was performed for patient age, number of oocytes collected, 
treatment type and date of oocyte collection (± six months). The clinical (CPR), 
implantation (IR), live birth (LBR) and miscarriage rates (MR) were calculated and 
considered significant at p<0.05 (Chi-square test). CPR, IR and LBR were found to be 
statistically significantly higher in the time-lapse system (TLS) group compared to the 
standard incubation group (CPR; 44.8% versus 36.5%, p<0.03. IR; 39.3% versus 32.2%, 
p<0.03. LBR; 43.1% versus 33.8%, p<0.01). Although there was a 5.5% decrease in the 
MR for the TLS group when compared to the standard incubation group, this result was 
not statistically significant (18.9% versus 24.4%, p>0.1). There is a paucity of well-
designed studies to confirm that embryos cultured and examined in TLS can result in 
superior treatment outcomes, and this strict-matched pair analysis with a large cohort of 
treatment cycles indicates the advantage of using TLS.  
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Introduction 
The first application of time-lapse systems (TLS) in embryology was recorded in 1968 
where chick embryos exposed to teratogenic doses of hypoxia were analysed (Grabowski 
and Schroeder, 1968). Following this studies relating to preimplantation embryonic 
development were published (Colly-d’Hooghe, Valleron, Malaise, 1977; Milligan, Harris, 
Dennis, 1978; Lueck and Aladjem, 1980; Massip and Mulnard, 1980; Milligan, Harris, 
Dennis, 1980; Schatten and Schatten, 1980; Alexandre and Mulnard, 1988). The first 
clinically relevant application of TLS for use in the embryology laboratory was reported 
in 1994 where the events of fertilisation were studied using a custom-made imaging 
system comprising a microscope, enabled with Nomarski DIC optics, a video recorder 
and a switching box (Inoué and Inoué, 1994). Regarding preimplantation embryonic 
development, the first report of internalisation of fragments was published (Hardarson et 
al.., 2002) followed by a report of mouse embryo collapse analysed using time-lapse 
photography (Niimura, 2003). Focus turned to the use of TLS in a clinical setting, quite 
abruptly, in 2008 with a number of publications exclusively studying preimplantation 
embryonic development using TLS and how the information these systems provided 
could be used to determine embryo viability (Arav et al., 2008; Lemmen, Agerholm, 
Ziebe, 2008; Mio and Maeda, 2008). The first commercially available TLS began 
installations in Europe in 2011. TLS for clinical application have now been readily 
adopted worldwide with instruments installed in numerous countries. The body of 
evidence suggests that TLS can increase the chances of a pregnancy for many undergoing 
assisted reproduction. However, contradictory evidence exists. The use of TLS in clinical 
laboratories allows for a detailed analysis of embryos contained within it giving over 700 
images per embryo compared to the conventional snap-shot observations translated into a 
written series of numbers and letters open to interpretation by other members of the 
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scientific team. The wealth of information that TLS provides inevitably creates the need 
to modify how embryos are selected for use and as such there are many reports linking 
time-lapse parameters (termed morphokinetics) to an embryos ability to create a 
pregnancy.  
 
A recent Cochrane review retrieved 33 articles relating to the use of TLS with only ten 
studies being potentially eligible for inclusion (Armstrong et al., 2014). After further 
evaluation, three studies were included as true RCTs. These trials totalled 994 couples 
with the majority contributed by one study (856) (Rubio et al., 2012). Following analysis 
it was concluded that for all types of TLS, with or without cell-tracking, embryo-scoring 
algorithms, versus standard embryo incubation there was no conclusive evidence of a 
difference in clinical pregnancy, miscarriage, live birth, and stillbirth rates per couple 
randomised. The aim of the following investigation was to examine whether TLS can be 
considered superior to standard incubation systems when considering CPR, IR, LBR and 
MR by performing a strict matched-pair analysis with a large cohort of patients.  
 
Methods 
Study Design 
A retrospective, observational, matched pair data analysis was designed and approved by 
the NHS Research Ethics Committee in the North West (ref: 14/NW/1043). Data for this 
research were obtained from 728 treatment cycles between January 2011 and September 
2014. This data comprised 364 patients having embryos cultured in a standard incubator 
(Sanyo Multigas MCO-18M, 37°C, 6% carbon dioxide (CO2)) (group 1) and 364 having 
their embryos cultured in a time-lapse enabled incubator, the EmbryoScope® (Vitrolife, 
Gothenburg, 37°C, 6% CO2, 5% oxygen (O2)) (group 2). Although in group 1 218 were 
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cultured in 20% O2 and 150 in 5% O2, a thorough statistical examination of the primary 
outcome of this investigation showed no significant differences between these groups 
which were then pooled. All treatments included in this analysis were from known 
implantation embryos i.e. a single embryo transfer or a double embryo transfer where 
transfer of two embryos resulted in either a negative pregnancy test or two fetal 
heartbeats. Clinical pregnancy (CPR), implantation (IR), live birth (LBR) and miscarriage 
(MR) rates were calculated.  
 
Patient criteria 
All patients with embryos cultured in the EmbryoScope® with known outcome were 
matched to patients having embryos cultured in a standard incubator for patient age 
(exact), number of oocytes collected (exact), treatment type and date of treatment (± six 
months).  Patients were not included twice. Patients were allocated to either standard or 
TLS culture randomly, based on availability. In February 2014 the laboratory became 
100% time-lapse enabled meaning all patients had all embryos cultured in a TLS.  
 
Ovarian stimulation  
Pituitary down-regulation was achieved with either a gonadotrophin releasing hormone 
agonist (buserelin, Suprecur®, Sanofi-Aventis, UK) or antagonist (cetrorelix acetate, 
Cetrotide®, Merck Serono, Germany). Ovarian stimulation was performed using urine 
derived or recombinant follicle stimulating hormone (Progynova (Bayer, Germany), 
Fostimon, Merional (IBSA, Switzerland), Menopur® (Ferring Fertility, Switzerland), 
Gonal-f® (Merck Serono). Doses were adjusted based on patient demographic and 
response.  
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Oocyte retrieval and embryology 
Ultrasound guided oocyte collection was performed transvaginally under sedation 
(Diprivan, Fresenius Kabi, USA). Collected oocyte-cumulus complexes were cultured in 
4-well dishes (Nunc™, Thermo Scientific, USA) containing 0.65ml G-IVF™ (Vitrolife) 
covered with 0.35ml OVOIL™ (Vitrolife) in a standard incubator. Sperm preparation was 
performed using a standard gradient separation at 0.3 relative centrifugal force for ten 
minutes (ISolate®, Irvine Scientific, USA) followed by two washes at 0.6rcf for ten 
minutes using G-IVF™. Those oocytes destined for ICSI were prepared using enzymatic 
(HYASE-10X™, Vitrolife) and mechanical digestion. ICSI was performed approximately 
four hours following collection after which time all injected oocytes were placed in 
individual culture drops of G-1™ (Vitrolife) and cultured in either the EmbryoScope® or 
a standard incubator. Those oocytes destined for standard insemination had this 
performed approximately four hours after collection and replaced into a standard 
incubator until fertilisation check the following day. Oocytes were then checked for 
fertilisation approximately 16-18 hours post-insemination (hpi) and all fertilised oocytes 
along with all unfertilised metaphase II oocytes were placed in individual culture drops of 
G-1™ and cultured in either the EmbryoScope® or a standard incubator. Where culture to 
day five was undertaken, a media change was performed on day three. For those embryos 
cultured in the EmbryoScope®, 20µl from each well was aspirated and replaced with 20µl 
of G-2™ (Vitrolife). For those embryos cultured in standard incubation, all embryos were 
moved to a new culture dish comprising individual 20µl drops of G-2™. Embryo 
selection for those cultured in the EmbryoScope® was performed using the national 
grading scheme (ACE/BFS guidelines, Cutting, Morroll, Roberts, Pickering, Rutherford, 
2008) along with an internally derived embryo-scoring, time-lapse algorithm. Embryo 
selection for those cultured in the standard incubator was performed using the national 
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grading scheme only. Embryo transfer was performed using the highest-grade embryo(s) 
either three or five days post collection depending on the number of good quality embryos 
the patient had on day three as well as how many were to be transferred. Selected 
embryos were cultured in EmbryoGlue® (Vitrolife) prior to embryo transfer.  
 
Statistical analyses 
CPR was calculated as the number of patients having a fetal heart beat (fhb) at 6-7 weeks 
gestation confirmed by ultrasound scan (regardless of number of fhb) out of the number 
of embryo transfers performed. IR was calculated as the total number of fhb (i.e. inclusive 
of higher order pregnancies) out of the number of embryos transferred. LBR was 
calculated as the number of all live births out of the number of embryo transfers. Finally, 
MR was calculated as the number of positive human chorionic gonadotrophin (hCG) tests 
that did not result in a fhb at ultrasound scan at 6-7 weeks gestation. Results were 
analysed using the Chi-square test (GraphPad Software Inc).  
 
Results 
A total of 728 treatment cycles were analysed and the CPR, IR, LBR and MR calculated 
(see table 1 for data breakdown). CPR, IR and LBR were found to be statistically 
significantly different between the two groups (table 2). The CPR for group 1 (control, 
standard incubation) when compared to group 2 (TLS) was 36.5% versus 44.8%, 
respectively, p < 0.03. The IR for group 1 when compared to group 2 was 32.2% versus 
39.3%, respectively, p < 0.03. The LBR for group 1 when compared to group 2 was 
33.8% versus 43.1%, respectively, p < 0.01. However, although there was a 5.5% increase 
in the MR for group 1 when compared to group 2, this result was not statistically 
significant (24.4% versus 18.9%, respectively, p > 0.1). 
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[table 1 near here] 
[table 2 near here] 
 
Discussion 
The results of this matched pair analysis reveal that embryos cultured and examined in the 
EmbryoScope® incubator result in superior treatment outcomes. These results are in 
concordance with others (Rubio et al., 2014; Yang et al., 2014; Adamson et al., 2015; 
Basile et al., 2015) but have been contradicted elsewhere (Nakahara et al., 2010; Cruz et 
al., 2011; Kirkegaard et al., 2012; Kahraman et al., 2013; Kovacs et al., 2013; Armstrong 
et al., 2014; Park et al., 2015). A recent Cochrane review (Armstrong et al., 2014) 
suggested that there was insufficient evidence to conclude that TLS with or without cell 
tracking technology would be beneficial to patients undergoing ART. Included in this 
were three eligible RCTs the first of which contributed most of the data for the review. 
This study was a multi-centre RCT of patients undergoing ICSI, using donated or 
autologous oocytes. 856 couples were randomised in this analysis; 444 to TLS and 412 to 
standard incubation. The CPR and MR were calculated as end-points. Although this 
analysis revealed a significant increase in treatment outcomes, considerable reasons for 
bias were identified. Firstly, patients could request the intervention (TLS) therefore 
allocation was, in fact, non-random.  Secondly, the study was classed as ‘double-blinded’ 
due to the gynaecologist and statistician being unaware of the arm to which the patients 
had been randomised. However, the patients and embryologists were given this 
information. Although unlikely to create a significant bias, this detail could invalidate the 
results. Finally, the heterogeneity of the sample was considerable including the use of 
donated, and thus both fresh and frozen oocytes (Rubio et al., 2014). The remaining two 
RCTs included in the review were conducted on a small number of couples, one being 
  9 
 
interim results only, leaving a combined total of 61 to 65 in each arm (Kahraman et al., 
2013; Kovacs et al., 2013). The reviewers reported a high risk of attrition bias in one of 
these studies due to the principal investigator undertaking the randomisation and also 
because there was no blinding. Overall, the reviewers stated that there was no conclusive 
evidence of a difference between standard incubation and TLS when considering CPR, 
MR, LBR and stillbirth rates.  Further analyses, not included in this Cochrane review, 
have also shown no significant differences in treatment outcomes between embryos 
cultured in standard incubation versus TLS (Nakahara et al., 2010; Cruz et al., 2011; 
Kirkegaard et al., 2012; Park et al., 2015).  
 
Differences in results found thus far in the matter of TLS could be attributed to a number 
of factors. Firstly, a benefit of TLS that one laboratory might enjoy may not be so with 
another due to the conditions of the laboratory in the first instance. In brief, a well-
designed, stable culture environment (TLS) introduced into what was a relatively unstable 
culture condition may elicit an immediate uplift in treatment outcomes. Whereas, to place 
this technology into an already optimal culture environment, may not reveal such results. 
There are many factors that vary between laboratories that could impact this; the type of 
culture media (single or sequential), culture dish type, volume of media used for culturing 
embryos, volume of oil overlay, the type of incubator and the embryo grading and embryo 
transfer policies. It is therefore reasonable to conclude that some laboratories may benefit 
from TLS more than others.  
 
Secondly, during the culture of embryos in the EmbryoScope® in this analysis an in-
house derived embryo-scoring algorithm was used. This indicates that the analysis 
presented here does not distinguish between the two, commonly stated, major benefits of 
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TLS; the undisturbed nature of the systems or the use of embryo-scoring algorithms. 
Whilst the authors acknowledge that this could create ambiguity, it can also be defended. 
This detail means that this analysis addresses TLS as a whole in the manner in which it 
should be utilised; using the information provided by the images. It also gives further 
explanation for the heterogeneity of success of TLS. Some laboratories utilising TLS have 
access to large amounts of data meaning in-house derivation and validation of predictive 
models can be performed; a method much preferred to utilising a published embryo-
scoring algorithm developed externally. In these laboratories, where internally derived 
models are used, although not proven, a greater benefit to using TLS would be expected. 
Naturally, in those laboratories that do not have access to a data-set allowing in-house 
derivation of predictive models, externally developed versions may be adopted, a decision 
which has been cautioned (Kirkegaard et al., 2013a; Yalçınkaya et al., 2014). Evidence of 
the benefits to using embryo-scoring algorithms can be seen clearly in the literature where 
the earliest publications regarding TLS aimed to assess the safety of the systems 
(Nakahara et al., 2010; Cruz et al., 2011; Freour et al., 2012; Kirkegaard et al., 2012). 
Many of these studies randomised oocytes or embryos between two culture systems 
(standard and TLS) and found no differences in treatment outcomes of embryo quality 
parameters. The use of an embryo-scoring algorithm in these studies is not mentioned, 
thus these analyses assessed the effectiveness of the incubator itself, not the information it 
provided. Once satisfaction with the safety of the system had been reached attention was 
then turned to how the information from the TLS could be utilised. Further reports were 
then published that revealed an uplift in outcome parameters (Rubio et al., 2014; 
VerMilyea et al., 2014; Yang et al., 2014; Basile et al., 2015; Milewski et al., 2015; 
Siristatidis et al., 2015) with one obvious difference; these analyses included the use of an 
embryo-scoring algorithm. A particular study, that evidences the above notion, 
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randomised 843 couples undergoing ICSI in a double-blinded manner to either standard 
incubation or TLS. Those embryos cultured in a standard incubator were assessed for 
selection based on morphology alone whereas those in TLS were selected using an 
internally derived, multivariable model. A significantly higher ongoing pregnancy rate 
was found in TLS compared to standard incubation (51.4% versus 41.7% per cycle and 
54.5% versus 45.3% per embryo transfer, respectively) as well as a significantly 
decreased early pregnancy loss in TLS (16.6% versus 25.8%). In addition, the 
implantation rate was significantly increased in the TLS group (44.9% versus 37.1%) 
(Rubio et al., 2014). A further investigation sought to select the most competent 
blastocysts for transfer by combining TLS and array comparative genomic hybridisation 
(aCGH) for patients undergoing preimplantation genetic screening (PGS) designed as a 
prospective study with sibling oocytes.  1163 metaphase II oocytes from 138 PGS patients 
were included and oocytes were randomised to two groups after ICSI; group A were 
cultured in TLS and group B in standard incubation. Array CGH using trophectodoerm 
biopsy on both groups was carried out and one or two euploid blastocysts either within the 
morphokinetic ranges (group A) or morphological grades (group B) were transferred. The 
clinical pregnancy and implantation rates were found to be significantly higher in group A 
when compared to group B (CPR; 71.1% versus 45.9%, IR; 66.2% versus 42.4%, 
respectively) demonstrating that when embryo-scoring algorithms are used as an adjunct 
to select embryos for transfer, superior treatment outcomes can be achieved (Yang et al., 
2014). These investigations address TLS as an incubator whilst also using the data it 
provides, synonymous with the current analyses, indicating that embryo-scoring 
algorithms derived using TLS are able to select embryos more effectively than standard 
morphology assessments. It is not surprising that an increase in treatment outcomes is 
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seen in these cases owing to the wealth of information that is available to the user of TLS 
to do basic, but powerful, embryo de-selection. 
 
Literature regarding TLS now predominantly concerns development of embryo-scoring 
algorithms or reviews concluding that further evidence for its (TLS) superiority is 
required. The authors believe that predictive models can be very useful, in the first 
instance for de-selection of embryos undergoing abnormal cleavage events such as direct 
cleavage and reverse cleavage shown to have a significantly reduced chance of creating a 
pregnancy (Rubio et al., 2012; Liu et al., 2014) but also, if developed effectively, to select 
the best embryo from a cohort for a specific patient demographic. Patient characteristics 
including infertility diagnosis (Sundvall et al.,2015) and maternal age (Hampl and 
Stephan, 2013; Chawla et al., 2015) as well as treatment characteristics including 
treatment type and culture conditions (Lemmen et al., 2008; Wale and Gardner, 2010; 
Cirayet al., 2012; Cruz et al., 2013; Kirkegaard et al., 2013b) have been shown to affect 
an embryo’s morphokinetic profile and the resulting subtle differences may be used to 
identify which embryo has the highest implantation potential. Herein lies a further reason 
for possible variation in success of TLS between laboratories; patient and treatment 
characteristics.  
 
Conclusion 
This matched pair analysis indicates that treatment cycles where embryos are cultured and 
examined in TLS result in superior outcomes including clinical pregnancy, implantation, 
live birth and miscarriage rates. Although the notion is novel, the authors believe that the 
real benefit of TLS lies in the development of patient specific embryo-scoring algorithms. 
Literature thus far indicates that there is likely to be no difference in treatment outcomes 
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when an embryo-scoring algorithm is not used and future research should be geared 
towards developing effective embryo-scoring algorithms to aid in embryo selection.  
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